European Commission secures EU access to Remdesivir for treatment of COVID-19

This article is brought to you in association with the European Commission. Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. As from early August onwards, and in […]